Bruker is a performace leader in preclinical imaging instrumentation. Bruker offers nine imaging modalities: PET, SPECT, CT, MRI, MPI, fluorescence, luminiscence, radioisotipic imaging and X-ray.
Discover
Back to filter
Show all topics (10)
Related topics
Understand the Cancer Ecosystem based on single cells analysis
Sep 22, 2022
Mission Bio is a life sciences company that accelerates discoveries and cures for a wide range of diseases by equipping...
Automating DNA Extraction for High-Throughput Bacterial Plasmid Purification with CyBi®-SELMA
Sep 19, 2022
The Need to Increase Plasmid Isolation Throughput, Challenges with Scaling up Plasmid DNA Extraction, Automating the...
Introducing RareCyte Orion, integrating Spatial Biology with Multiplex Imaging
Sep 13, 2022
Orion, the highly multiplexed fluorescent imaging system, empower investigators to unlock spatial context for key...
Cytek Aurora at CIVIS Summer School
Aug 23, 2022
OMIXYS´s workshop during CIVIS project for spectral flowcytometry, using Aurora from Cytek
xCELLigence eSight - Imaging & Impedance in real-time inside your incubator
Aug 22, 2022
The xCELLigence RTCA eSight enables comprehensive insight into cell health, cell behavior, cell function and cell...
Standardize tumor sample preparation and reduce background with Curiox laminar wash system
Aug 10, 2022
Laminar Wash technology offers a gentle alternative that can improve yield and data quality, particularly of rare cell...
Developing a 43 color panel on Cytek Aurora using Laminar Wash for sample prep
Aug 2, 2022
Successfully executing a 43 color panel is a technically demanding task. One that is made more difficult when there are...
Transcriptome-Informed Approach to Drug Discovery
Jul 12, 2022
The HTG EdgeSeq system is a powerful molecular profiling tool for biopharmaceutical companies, academic research...
Semi-automated genomic DNA extractionfrom Plant with CyBi®-SELMA
Jul 12, 2022
Plant genomic DNA extraction with CyBio SELMA, Semi-Automated Pipette with minimal benchtop footprint
New Center of Excellence, located at the Josep Carreras Leukaemia Research Institute
Jul 12, 2022
Mission Bio is a life sciences company that accelerates discoveries and cures for a wide range of diseases by equipping...
3R Compliant drug development studies
Jun 8, 2018
Using an ultrasound instrument, animal throughput can be low and operators also need to be highly experienced simply to even find certain organs.
At the Center for Molecular Oncology at Barts Cancer Institute, Queen Mary University of London, researchers have been using preclinical imaging to look at the pharmacokinetics of radiopharmaceuticals, to perform anatomical studies, and to assess treatment responses in mice. The center is fully equipped for radiopharmaceutical development and houses a number of imaging instruments.
One of those instruments is the ICON 1 T MRI from Bruker. In a recent interview, team leader Dr. Jane Sosabowski, explained how the molecular imaging team have been using the ICON to investigate orthotopic pancreatic tumors in mice and described some of the advantages of using this over ultrasound.
Brand profile
